Prolonged release formulations comprising a 2-oxo-1-pyrrolidine derivative

摘要

The present invention relates to a pharmaceutical composition comprising Levetiracetam, Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation.